Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02762929 · ClinicalTrials.gov registry record · Phase 2
Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
A Phase 2 study, sponsored by Heron Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 430
- Enrollment target
NCT02762929 is a Phase 2 study that has completed, run by Heron Therapeutics. The registered enrollment target is 430 participants.
The verdict
NCT02762929, a Phase 2 study, has completed, sponsored by Heron Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 430 participants
- Enrollment target
Study Summary
A Phase 2, Randomized, Controlled, Multicenter, Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
Interventions
- DRUG Bupivacaine HCl
- DRUG HTX-002
- DRUG HTX-011A
- BIOLOGICAL Saline Placebo
- DRUG HTX-011B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02762929
The ClinicalTrials.gov registry entry for NCT02762929 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 430 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heron Therapeutics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Bupivacaine HCl is the first listed.
NCT02762929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02762929 about?
NCT02762929 is a clinical study titled "Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy". A Phase 2, Randomized, Controlled, Multicenter, Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
What is the current status of trial NCT02762929?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 430 participants. The study started on 2016-05. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02762929?
The interventions under investigation include: Bupivacaine HCl (DRUG), HTX-002 (DRUG), HTX-011A (DRUG), Saline Placebo (BIOLOGICAL), HTX-011B (DRUG).
Who is sponsoring clinical trial NCT02762929?
This trial is sponsored by Heron Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.